Randomized, double-blind, multicenter study to compare the safety and efficacy of viramidine [taribavirin] to ribavirin in treatment-naive patients with chronic hepatitis C

Trial Profile

Randomized, double-blind, multicenter study to compare the safety and efficacy of viramidine [taribavirin] to ribavirin in treatment-naive patients with chronic hepatitis C

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Oct 2016

At a glance

  • Drugs Peginterferon alfa-2a; Ribavirin; Taribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms VISER2
  • Most Recent Events

    • 21 Jun 2012 Actual end date (1 May 2006) added as reported by ClinicalTrials.gov.
    • 21 Jun 2012 Additional lead trial investigator (Doyle RT) added as reported by ClinicalTrials.gov.
    • 03 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top